Media Articles Related to Ortho (Ethinyl Estradiol)
Orthopedic Group Pays Big Fine for HIPAA Violation
Source: Medscape Business of Medicine Headlines [2016.04.25]
The Office of Civil Rights has sent a signal that it will crack down on violators of the HIPAA rule requiring business associate agreements; starts new round of audits.
Medscape Medical News
Source: MedicineNet Addison Disease Specialty [2015.05.14]
Title: Orthostatic Hypotension
Category: Diseases and Conditions
Created: 6/11/2009 12:00:00 AM
Last Editorial Review: 5/14/2015 12:00:00 AM
Making Medicare's Hip and Knee Replacement Bundles Work
Source: Medscape General Surgery Headlines [2016.04.28]
If surgeons and staffers in other hospital departments can reengineer care delivery in a coordinated effort, Medicare's new bundling program can be profitable. Here's how some hospitals are doing it.
Radiation exposure increases risk of health problems for medical staff
Source: Radiology / Nuclear Medicine News From Medical News Today [2016.04.13]
Health care workers who perform fluoroscopy for heart procedures are at greater risk for orthopedic problems, cataracts, skin lesions and cancers, new research finds.
Digital fitness devices help patients monitor health and activity, improve outcomes
Source: Rehabilitation / Physical Therapy News From Medical News Today [2016.03.07]
Apps allow patients to share data with their doctor.Many orthopaedic patients are eager to track and improve their health and progress before, during and after treatment.
Published Studies Related to Ortho (Ethinyl Estradiol)
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3
mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric
disorder: a randomized, double blind placebo-controlled study]. [Article in Chinese] 
with placebo in reducing symptoms of premenstrual dysphoric disorder (PMDD)... CONCLUSIONS: YAZ could improve symptoms of PMDD better than placebo, while
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90
mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual
and premenstrual syndrome (PMS)... CONCLUSIONS: These data, although not consistent, indicate that continuous LNG/EE
Bond strength of orthodontic light-cured resin-modified glass ionomer cement. [2011.04]
The purpose of this study was to compare the bond strengths and debonded interfaces achieved with light-cured resin-modified glass ionomer cement (RMGIC) and conventional light-cured composite resin. In addition, the effects of acid etching and water contamination were examined... Enamel surfaces, with or without water contamination and with or without acid etching, had the same or a greater bond strength than Transbond.
In-vitro evaluation of various treatments to prevent demineralization next to orthodontic brackets. [2010.12]
INTRODUCTION: One common negative side effect of orthodontic treatment with fixed appliances is the development of incipient caries lesions around brackets, particularly in patients with poor oral hygiene. Bio-available minerals from cement containing amorphous calcium phosphate (ACP) might facilitate remineralization and inhibit lesion development. Our objective was to compare the potential of ACP-containing resin cement, fluoride varnish, resin sealer, and MI Paste (GC America, Alsip, Ill) under similar in-vitro conditions to prevent incipient caries lesions next to brackets on teeth... CONCLUSIONS: Both light-cured filled resin (Pro-seal) and fluoride varnish (Vanish) might prevent enamel demineralization next to orthodontic brackets exposed to cariogenic conditions, but the observed positive effects of Aegis-Ortho and MI Paste were not significant. Copyright (c) 2010 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.
Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects. [2010.12]
BACKGROUND: Limited orthodontics are shown to be effective in the correction of infrabony defects. Studies have also demonstrated the efficacy of using enamel matrix derivative (EMD) with demineralized freeze-dried bone allograft (DFDBA) to treat infrabony defects. This study aims to compare the clinical efficacy of limited orthodontics combined with EMD/DFDBA in the treatment of 2- or 3-wall infrabony defects... CONCLUSION: Although both treatment modalities were effective in managing 2- or 3-wall infrabony defects, limited orthodontics provided an additional benefit to EMD/DFDBA in 2-wall defects.
Clinical Trials Related to Ortho (Ethinyl Estradiol)
The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA� in Healthy Women [Completed]
The purpose of this study is to assess the bioequivalence of the contraceptive hormones of
ORTHO EVRA when the patch is applied with and without an adhesive overlay.
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks [Active, not recruiting]
The purpose of the study is to assess the occurrence of venous thromboembolism (blood
clots), stroke, and heart attack in current users of ORTHO EVRA compared to current users of
norgestimate-containing oral contraceptives with 35 mcg ethinyl estradiol with special
attention to duration of use. The study uses data from the PharMetrics Patient-Centric
Database, which is a medical claims database.
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen� in Healthy Female Subjects [Completed]
Discontinuation of Lens Wear in New Ortho-k Children (DOEE2) [Active, not recruiting]
Continuous Use of the Contraceptive Patch and the Personal Economic Impact. [Withdrawn]
Dr. Eleanor Drey in the Department of Obstetrics, Gynecology and Reproductive Sciences UCSF
is conducting a study to examine the personal and economic impact of continuous use of ORTHO
EVRA, the contraceptive patch, on menstrual related symptoms for women who report having
severe menstrual related symptoms.